SECsense Logo

Reviva Pharmaceuticals 8-K Report: Key Updates & Stock Info for Investors

$RVPH
Form 8-K
Filed on: 2024-12-18
Source
Reviva Pharmaceuticals 8-K Report: Key Updates & Stock Info for Investors

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Reviva Pharmaceuticals Holdings, Inc.
  • CIK (Central Index Key): 0001742927
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-38634
  • EIN (Employer Identification Number): 85-4306526
  • Address: 10080 N Wolfe Road Suite SW3-200, Cupertino, CA 95014
  • Phone Number: 408-501-8881
  1. Filing Type:
  • Form Type: 8-K (Current Report)
  1. Reporting Date:
  • Date of Filing: December 16, 2024
  1. Stock Information:
  • Common Stock: Trading symbol RVPH on NASDAQ.
  • Warrants: Warrants to purchase one share of Common Stock with the trading symbol RVPHW on NASDAQ.
  1. Context Information:
  • Period of Reporting: The reporting period is for December 16, 2024.
  • Statement Class of Stock: Indicates details about classes of stock, specifically:
    • Common Stock
    • Warrants to Purchase One Share of Common Stock

This information provides a snapshot of Reviva Pharmaceuticals Holdings, Inc., including its basic corporate data, the nature of its securities, and the context of the financial report filed with the SEC. The filing is significant as it may contain updates relevant to investors regarding the company's operations or financial condition.